ALX ONCOLOGY HOLDINGS INC Proceeds from Issuance of Debt
ALX ONCOLOGY HOLDINGS INC (ALXO) reported Proceeds from Issuance of Debt of $10.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2026-08-06
- ALX ONCOLOGY HOLDINGS INC proceeds from issuance of debt for fiscal 2022 was $10.00M.
- ALX ONCOLOGY HOLDINGS INC proceeds from issuance of debt for fiscal 2019 was $5.92M.
| Period end | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|
| 2026-06-30 | $10.00M 10-Q · filed 2026-08-06 | |
| 2022-12-31 | $10.00M 10-K · filed 2025-03-06 | |
| 2019-12-31 | $5.92M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |